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Eye ( I read with interest the paper by FH Zaidi and colleagues titled 'The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes ' (Eye 2004; 18: 503-508) .
Their work deserves commendation for bringing confirmation to our clinical observations and experience that 87% of threshold scotomas were not detected by black and white Amsler grid when the field defect is less than 61 (6 squares) on the grid. Authors report that a mere 29% of eyes with subretinal neovascular lesions were detected by high-contrast black-and-white Amsler grid testing. Unfortunately, it is not known what real visual deficits, both in terms of a scotoma as well as visual distortion, that is metamorphopsia, their 100 patients actually had at the time of presentation. In other words, the Amsler grid would detect vision deficit only if there is one, and there may not be anything to detect in some of their patients who passed the Amsler test for they were not checked with threshold perimetry or ideally with Fundus Scanning Laser Projection Perimetry. We also do not know the extent and severity of the organic lesions that was detected by the Amsler grid against the ones that passed the test. I believe it is important for this reason not to conclude that subjective vision tests with alternative macular test grids and colour-contrast tests would continue to be of limited usefulness in the future.
The red-on-black chart, the classical colour-contrast test version, of the Amsler grid is too difficult to be seen (very low contrast) by most patients and creates an unacceptably high false-alarm rate. Furthermore, none of the Amsler grid variations made available to date fully utilized the testing potential of their background at the same time as the foreground grid lines as the stimuli. Most retinal and macular lesions, such as macular degeneration or medication toxicity, cause quantifiable contrast sensitivity loss 1,2 and a blue-yellow defect, whereas optic nerve, chiasmal, and postchiasmal disorders (with the exception of dominantly inherited optic atrophy associated traditionally with a blue-yellow defect) cause a red-green defect.
3-7 Colour field test cards based on the colour desaturation test technique utilizing the background at the same time as the grid lines with low and intermediate calibrated contrasts of blue-onyellow, blue-on-red, and white-on-red combinations are available (www.ixm.us; Figure 1a -d). These versions of the Amsler charts may detect early visual field defects of 5 decibels depth that may be coassociated with approximately 25% washed-out or darkened colour appearance easily noticeable by an average observer, also providing over 90% detection sensitivity and 90% specificity in neuro-ophthalmic practice. 6 The authors correctly point out the need for an alternative to the conventional high-contrast achromatic Amsler to improve its limited detection sensitivity for screening and the above-described new versions may just be the answer for this need. He told me how important it is to explain to the patient that the gaze must be fixed on the central spot while being aware of the whole chart. Questions were to be put in a strict sequence. Can you see the central spot? While looking at the spot and not moving your eye can you see the four corners? The four sides? Is any of the pattern missing? Distorted? Blurred?
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In his paper delivered to the Oxford Congress, Amsler gave several examples of the usefulness of the test. (Amsler M. Quantitative and qualitative vision. Trans Ophthalmic Soc UK 1949; 69: 397-410, 9 Figs). Duke Elder also describes the method with illustrations (Duke-Elder S. System of Ophthalmology, Vol 7. Kimpton: London, 1962, pp 396-397) .
In the booklet of Amsler charts, a pad of recording sheets was provided for convenience but not as an alternative. It appears that in recent years, the recording sheets have been given to patients at risk of macular disturbance asking them to use them at intervals to observe any distortion of the lines.
In my own practice, I have found that patients with central scotoma or metamorphopsia find difficulty in appreciating the defect on the recording charts, but do so easily on the proper white on black charts. This amply confirmed Professor Amsler's experience. Sir, More than meets the eye: alternatives to black-on-white visual field testing
MJ
The informative comments by Mr Roper-Hall and Dr Mutlukan are valued contributions to understanding the background to much modern psychophysical testing of the central visual field. The original quotes from Professor Amsler are very relevant to current practice in the use of Amsler grids and are sure to educate many contemporary ophthalmologists. Indeed, one cannot help but wonder why the current black grids on white paper were introduced, presumably as they would seem to be easier to print and thus might be more cost-effective in our predominantly state-run healthcare system in the United Kingdom.
We would emphasise, however, that our study was not to determine which type of chart is the best to use, nor the extent of visual field loss it detected, but rather an assessment of methodology that is normal current practice. 1 We found that the British National Health Service most often uses the Chart No. 1 by Keeler: a black grid on a white background. In short, our study found this to be an unsatisfactory test and Professor Amsler's original comments may indeed partly explain this. However, we stress that Amsler charts should continue to be dispensed as they do detect a fair proportion of subretinal membranes (approximately 30% in our study using black on white charts).
The significance of this area is increasing considerably with PDT laser and other treatment modalities for age-related macular degeneration that require early reliable detection of subretinal neovascular membranes.
